Prelude Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,567
| Closed | -$35.5K | – | 1267 |
|
|
2024
Q1 | $35.5K | Buy |
+1,567
| New | +$35.5K | ﹤0.01% | 1151 |
|
|
2023
Q3 | – | Sell |
-1,062
| Closed | -$28.5K | – | 1113 |
|
|
2023
Q2 | $28.5K | Sell |
1,062
-1,766
| -62% | -$47.4K | ﹤0.01% | 883 |
|
|
2023
Q1 | $165K | Sell |
2,828
-1,074
| -28% | -$62.7K | 0.01% | 802 |
|
|
2022
Q4 | $199K | Buy |
3,902
+3,003
| +334% | +$153K | 0.01% | 839 |
|
|
2022
Q3 | $74K | Buy |
899
+113
| +14% | +$9.3K | ﹤0.01% | 1162 |
|
|
2022
Q2 | $53K | Buy |
+786
| New | +$53K | ﹤0.01% | 1255 |
|
|
2022
Q1 | – | Sell |
-1,400
| Closed | -$135K | – | 1718 |
|
|
2021
Q4 | $135K | Hold |
1,400
| – | – | ﹤0.01% | 1297 |
|
|
2021
Q3 | $122K | Hold |
1,400
| – | – | ﹤0.01% | 1123 |
|
|
2021
Q2 | $217K | Hold |
1,400
| – | – | 0.01% | 1091 |
|
|
2021
Q1 | $221K | Buy |
1,400
+173
| +14% | +$27.3K | 0.01% | 900 |
|
|
2020
Q4 | $285K | Hold |
1,227
| – | – | 0.01% | 531 |
|
|
2020
Q3 | $269K | Sell |
1,227
-41
| -3% | -$8.99K | 0.01% | 422 |
|
|
2020
Q2 | $360K | Buy |
+1,268
| New | +$360K | 0.02% | 363 |
|
|
2020
Q1 | – | Sell |
-9
| Closed | -$3K | – | 1268 |
|
|
2019
Q4 | $3K | Buy |
+9
| New | +$3K | ﹤0.01% | 1321 |
|
|
2019
Q3 | – | Sell |
-102
| Closed | -$9K | – | 1395 |
|
|
2019
Q2 | $9K | Buy |
102
+81
| +386% | +$7.15K | ﹤0.01% | 1038 |
|
|
2019
Q1 | $2K | Sell |
21
-3
| -13% | -$286 | ﹤0.01% | 1282 |
|
|
2018
Q4 | $3K | Sell |
24
-9
| -27% | -$1.13K | ﹤0.01% | 1299 |
|
|
2018
Q3 | $8K | Buy |
33
+14
| +74% | +$3.39K | ﹤0.01% | 1170 |
|
|
2018
Q2 | $5K | Buy |
+19
| New | +$5K | ﹤0.01% | 1266 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1455 |
|
|
2017
Q4 | – | Sell |
-120
| Closed | -$20K | – | 1405 |
|
|
2017
Q3 | $20K | Buy |
+120
| New | +$20K | ﹤0.01% | 1198 |
|
|
2017
Q1 | – | Sell |
-2,146
| Closed | -$303K | – | 1567 |
|
|
2016
Q4 | $303K | Buy |
+2,146
| New | +$303K | 0.04% | 405 |
|